4.6 Review

cAMP-Dependent Signaling and Ovarian Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Exploiting systems biology to investigate the gene modules and drugs in ovarian cancer: A hypothesis based on the weighted gene co-expression network analysis

Samira Nomiri et al.

Summary: The study revealed the involvement of blue module genes in ovarian cancer progression, with specific gene modules related to biological processes such as the cAMP signaling pathway. Key hub genes associated with serous OC were identified, including ADORA1, ANO9, SERINC2, and KLHL14. These genes may serve as novel candidate target genes for treating OC.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Oncology

Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium

Phyllis van der Ploeg et al.

Summary: This study investigated the activity of key signal transduction pathways in serous tubal intraepithelial carcinoma (STIC) and high-grade serous carcinoma (HGSC) and compared them to normal Fallopian tube epithelium (FTE). The results showed that the ER pathway activity was lower, while the PI3K and HH pathway activity was higher in STIC and HGSC compared to FTE. This suggests that these pathways may play a crucial role in the neoplastic transformation of FTE into STIC.

GYNECOLOGIC ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies

Stephanie Chauvin et al.

Summary: This review provides a comprehensive overview of the role of E2 in female folliculogenesis and the various effects of ERβ splice isoforms. It also discusses how deregulation of E2 signaling can lead to two ovarian pathologies and emphasizes the need for further research.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Oncology

The Evolution of Ovarian Carcinoma Subclassification

Martin Kobel et al.

Summary: Research has shown that ovarian carcinomas consist of multiple distinct histologic types and molecular subtypes, representing different diseases. By grouping tumors based on molecular similarities, research and future patient management can be facilitated. Utilizing immunohistochemical markers and histotype-specific oncogenic alterations can confirm morphological diagnoses for different histotypes.

CANCERS (2022)

Article Cell Biology

The granulosa cell response to luteinizing hormone is partly mediated by YAP1-dependent induction of amphiregulin

Philippe Godin et al.

Summary: This study found that LH hormone activates the Hippo signaling pathway in murine granulosa cells through protein kinase A. Yap1 and Taz play important roles in regulating the LH signaling pathway, as they are involved in the induction of multiple LH target genes and the activation of the ERK1/2 pathway. The collaboration between the Hippo signaling pathway and the cAMP/PKA and ERK1/2 pathways ensures the precise regulation of the LH cascade, and YAP1 directly targets Areg to mediate its actions in the ovary.

CELL COMMUNICATION AND SIGNALING (2022)

Review Physiology

PHYSIOLOGICAL ROLES OF MAMMALIAN TRANSMEMBRANE ADENYLYL CYCLASE ISOFORMS

Katrina F. Ostrom et al.

Summary: Adenylyl cyclases (ACs) catalyze the conversion of ATP to cAMP, serving as major effectors of G protein-coupled receptors (GPCRs) with varying expression patterns across tissues. Understanding the potential roles of each isoform holds promise for uncovering new therapeutic approaches.

PHYSIOLOGICAL REVIEWS (2022)

Article Cell Biology

HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer

Hanlin Ma et al.

Summary: This study found that the overexpression of HMGB3 is associated with shorter overall survival and drug resistance in high-grade serous ovarian carcinoma. HMGB3 interacts with PARP1 to promote PARPi resistance, and targeted inhibition of HMGB3 may overcome PARPi resistance in ovarian cancer therapy.

CELL DEATH & DISEASE (2022)

Article Cell Biology

The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP

Wei Yue et al.

Summary: BRCA1 deficiency activates the cAMP signaling pathway and leads to apoptotic resistance in ovarian cancer cells. This study reveals a novel mechanism of apoptotic resistance and suggests a potential strategy for treating BRCA1-mutated tumors using ADRBI inhibition to kill cancer cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Biochemistry & Molecular Biology

PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them

Dongha Kim et al.

Summary: PARP inhibitors, the first clinically approved drugs based on synthetic lethality, have shown promising outcomes in the treatment of cancer patients. Resistance development remains a challenge, but efforts are being made to overcome it and enhance the efficacy of PARP inhibitors. Mechanisms of action, causes of resistance, and innovative attempts to degrade PARP proteins are discussed in this study.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy

Min Wei et al.

Summary: This study identified novel biomarkers and potential small molecule drugs in ovarian cancer (OC) through analysis of gene expression datasets. Six hub genes with potential prognostic value and high expression rates in OC tissues were identified. These findings have implications for the diagnosis and treatment of OC.

TRANSLATIONAL CANCER RESEARCH (2022)

Review Cell Biology

cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach

Muhammad Bilal Ahmed et al.

Summary: Cancer, one of the leading causes of death globally, remains unclear in its fundamental principles. Understanding the key signaling mechanisms that cause cancer cell malignancy may help uncover new pharmaco-targets. Targeting cAMP and its effectors, crucial for tumor growth and development, may serve as a useful cancer treatment strategy.
Review Oncology

Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy

Rui Guo et al.

Summary: The ADCY superfamily, a group of glycoproteins regulating intracellular signaling, plays a key role in the cyclic adenosine monophosphate (cAMP) signaling pathway and is related to cell sensitivity to chemotherapy and radiation. Overactivation of ADCY and its regulators is considered a major target for anticancer therapies and markers of exceptional responders to chemotherapy. In this review, the focus is on the oncogenic functions of the ADCY family and the possibility of using harmful nsSNPs in ADCY as a prognostic therapeutic target in modulating resistance to chemotherapy and immunotherapy. The review also assesses the roles of ADCY and its counterparts as stress regulators in cancer cell metabolism and the tumor microenvironment, and highlights well-evaluated inhibitors of ADCY-related signaling that are under clinical investigation. Understanding ADCY-induced signaling and harmful nsSNPs in ADCY6 provides new opportunities for personalized oncology and enhancing chemoimmunotherapy efficacy in treating various cancers.

FRONTIERS IN ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Deregulated miRNA clusters in ovarian cancer: Imperative implications in personalized medicine

Amoolya Kandettu et al.

Summary: This review summarizes the regulation and biological function of miRNA clusters in ovarian cancer, highlighting their utility in clinical management.

GENES & DISEASES (2022)

Article Cell Biology

A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation

Marek M. Drozdz et al.

Summary: Nuclear cAMP microdomains can activate a tumor-suppressive pathway in a broad range of cancers by inhibiting the key effector protein YAP of the Hippo pathway.

CELL REPORTS (2022)

Article Pharmacology & Pharmacy

Strategies to safely target widely expressed soluble adenylyl cyclase for contraception

Jacob Ferreira et al.

Summary: This article discusses the 10 isoforms of adenylyl cyclase that produce the second messenger cyclic AMP in humans, including nine G protein-coupled transmembrane adenylyl cyclases (tmACs; ADCY1-9) and one bicarbonate-regulated soluble adenylyl cyclase (sAC; ADCY10). It highlights the unique druggability of sAC and outlines approaches to target sAC for novel forms of male and female contraception.

FRONTIERS IN PHARMACOLOGY (2022)

Review Oncology

Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening

Jue Hou et al.

Summary: Molecular targeted therapy has significantly improved cancer treatment by providing better therapeutic responses and reducing systemic toxicity. However, therapeutic resistance remains a major challenge, hindering the continuous clinical benefits for cancer patients. The recent development of advanced technologies, such as CRISPR-Cas9 screening and patient-derived models, has provided powerful tools to understand the underlying mechanisms of resistance in targeted cancer therapies. This review explores therapeutic targets and the high-throughput CRISPR-Cas9 screening technology, which can uncover potential mechanisms of unresponsiveness and guide the development of next-generation anti-cancer drugs.

FRONTIERS IN ONCOLOGY (2022)

Review Pharmacology & Pharmacy

Subcellular Organization of the cAMP Signaling Pathway

Manuela Zaccolo et al.

Summary: Recent developments in the field of cAMP signaling have highlighted the importance of cAMP compartmentalization and the complex network through which cAMP signals propagate. Understanding the spatial regulation of cAMP levels and selective activation of signaling branches within the network is crucial for determining specific functional outcomes and potential disease mechanisms. This knowledge offers new insights into cell physiology and opens avenues for innovative therapeutic interventions.

PHARMACOLOGICAL REVIEWS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Reproductive Biology

Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics

Alexandra Franz et al.

Summary: This study utilized mass spectrometry-based proteomics to characterize the response of HGSOC cells to PARP1 inhibitors, revealing significant proteomic changes in cancer cells treated with PARP1 inhibitors. The findings suggest potential protein targets for therapeutic inhibition in combination with PARP1 inhibitors, and highlight the importance of rational design of combination therapies in ovarian cancer.

JOURNAL OF OVARIAN RESEARCH (2021)

Review Cell Biology

Regulation of Mitochondrial Homeostasis by sAC-Derived cAMP Pool: Basic and Translational Aspects

Muhammad Aslam et al.

Summary: This article discusses the role of mitochondria not only as a source of cellular energy, but also as key regulators of various cellular processes. Research shows that cAMP signaling plays a significant role in mitochondrial biology and homeostasis, with sAC being a crucial enzyme for cAMP synthesis within mitochondria. Disruption of sAC-dependent cAMP pools in mitochondria can lead to mitochondrial dysfunction and pathologies.
Review Medicine, General & Internal

What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors

Antonio De Leo et al.

Summary: Ovarian carcinomas are a heterogeneous group of neoplasms with different types and characteristics. The WHO classifies them into five distinct types, each with unique molecular features. Advances in molecular pathology have improved our understanding of ovarian carcinomas and can guide personalized clinical decisions.

DIAGNOSTICS (2021)

Article Health Care Sciences & Services

Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer

Chia-Jung Li et al.

Summary: The study reveals higher expression of CREB1 gene in ovarian cancer tissue compared to normal tissue, and indicates that high expression of CREB1 gene may lead to poor prognosis. Targeting CREB1 could be a potential tool for the diagnosis and treatment of ovarian cancer.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Oncology

Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers

David W. Chan et al.

Summary: The study revealed a significant association of global DNA hypermethylation with poor prognosis and drug resistance in high-grade EOC, while demonstrating the potential of demethylating agents in cancer treatment.

CLINICAL EPIGENETICS (2021)

Review Pharmacology & Pharmacy

Cyclic nucleotide phosphodiesterases: New targets in the metabolic syndrome?

Claire Lugnier et al.

PHARMACOLOGY & THERAPEUTICS (2020)

Article Biochemistry & Molecular Biology

The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines

Dominika Kazmierczak et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

The forefront of ovarian cancer therapy: update on PARP inhibitors

M. R. Mirza et al.

ANNALS OF ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Newly Identified Regulators of Ovarian Folliculogenesis and Ovulation

Eran Gershon et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline

William P. Tew et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

PARP inhibitor resistance: the underlying mechanisms and clinical implications

He Li et al.

MOLECULAR CANCER (2020)

Article Oncology

CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET

Shuyang Wang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms

Eleonora A. Braga et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Complex roles of cAMP-PKA-CREB signaling in cancer

Hongying Zhang et al.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)

Article Oncology

Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer

Ju-Yueh Li et al.

CANCER CONTROL (2020)

Article Biochemistry & Molecular Biology

The Role of CASC2 and miR-21 Interplay in Glioma Malignancy and Patient Outcome

Daina Skiriute et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Role of Phosphodiesterase in the Biology and Pathology of Diabetes

Agnieszka Kilanowska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Oncology

Ras and Rap1: A tale of two GTPases

Seema Shah et al.

SEMINARS IN CANCER BIOLOGY (2019)

Review Oncology

PARP inhibitors in ovarian cancer

Elisena Franzese et al.

CANCER TREATMENT REVIEWS (2019)

Review Oncology

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy

Shuang Qin et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Oncology

Ovarian Cancer: An Integrated Review

Christine Stewart et al.

SEMINARS IN ONCOLOGY NURSING (2019)

Review Endocrinology & Metabolism

Molecular Mechanisms of Action of FSH

Livio Casarini et al.

FRONTIERS IN ENDOCRINOLOGY (2019)

Review Oncology

A decade of clinical development of PARP inhibitors in perspective

J. Mateo et al.

ANNALS OF ONCOLOGY (2019)

Article Medicine, Research & Experimental

CREB1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis

Lingling Tong et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Oncology

Targeting mTOR for cancer therapy

Hui Hua et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Reproductive Biology

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets

Kaipeng Xie et al.

JOURNAL OF OVARIAN RESEARCH (2019)

Review Biochemistry & Molecular Biology

PAK4 signaling in health and disease: defining the PAK4-CREB axis

So-Yoon Won et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2019)

Article Pharmacology & Pharmacy

cAMP Signaling Compartmentation: Adenylyl Cyclases as Anchors of Dynamic Signaling Complexes

Timothy B. Johnstone et al.

MOLECULAR PHARMACOLOGY (2018)

Article Medicine, Research & Experimental

From Ras to Rap and Back, a Journey of 35 Years

Johannes L. Bos

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Article Biochemistry & Molecular Biology

Shaping mitochondrial dynamics: The role of cAMP signalling

Giulietta Di Benedetto et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Review Endocrinology & Metabolism

Two Hormones for One Receptor: Evolution, Biochemistry, Actions, and Pathophysiology of LH and hCG

Livio Casarini et al.

ENDOCRINE REVIEWS (2018)

Review Cell Biology

Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment

Naveen Kumar et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)

Review Biochemistry & Molecular Biology

New insights into long noncoding RNAs and their roles in glioma

Zixuan Peng et al.

MOLECULAR CANCER (2018)

Review Pharmacology & Pharmacy

Pharmacological modulation of the CO2/HCO3-/pH-, calcium-, and ATP-sensing soluble adenylyl cyclase

Shakarr V. Wiggins et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Physiology

INTRACELLULAR cAMP SENSOR EPAC: PHYSIOLOGY, PATHOPHYSIOLOGY, AND THERAPEUTICS DEVELOPMENT

William G. Robichaux et al.

PHYSIOLOGICAL REVIEWS (2018)

Article Endocrinology & Metabolism

Multiple cAMP Phosphodiesterases Act Together to Prevent Premature Oocyte Meiosis and Ovulation

Giulia Vigone et al.

ENDOCRINOLOGY (2018)

Review Obstetrics & Gynecology

The cAMP/PKA pathway: steroidogenesis of the antral follicular stage

Laura Riccetti et al.

MINERVA GINECOLOGICA (2018)

Review Multidisciplinary Sciences

PARP inhibitors: Synthetic lethality in the clinic

Christopher J. Lord et al.

SCIENCE (2017)

Article Multidisciplinary Sciences

High grade serous ovarian carcinomas originate in the fallopian tube

S. Intidhar Labidi-Galy et al.

NATURE COMMUNICATIONS (2017)

Review Oncology

The disparate origins of ovarian cancers: pathogenesis and prevention strategies

Anthony N. Karnezis et al.

NATURE REVIEWS CANCER (2017)

Article Pharmacology & Pharmacy

Amplification of FSH signalling by CFTR and nuclear soluble adenylyl cyclase in the ovary

Hui Chen et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)

Review Cell Biology

The many faces of compartmentalized PKA signalosomes

Omar Torres-Quesada et al.

CELLULAR SIGNALLING (2017)

Review Obstetrics & Gynecology

Pathogenesis and heterogeneity of ovarian cancer

Paul T. Kroeger et al.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2017)

Article Multidisciplinary Sciences

Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types

Cheng Wang et al.

NATURE COMMUNICATIONS (2016)

Article Oncology

The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein

Lavoisier Ramos-Espiritu et al.

ONCOTARGET (2016)

Article Multidisciplinary Sciences

Protein Kinase A: A Master Kinase of Granulosa Cell Differentiation

Pawan Puri et al.

SCIENTIFIC REPORTS (2016)

Article Cell Biology

Distribution and function of 3′,5′-Cyclic-AMP phosphodiesterases in the human ovary

T. S. Petersen et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)

Review Cell Biology

Signalling scaffolds and local organization of cellular behaviour

Lorene K. Langeberg et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)

Review Oncology

The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges

Bianca Cheaib et al.

CHINESE JOURNAL OF CANCER (2015)

Review Biochemistry & Molecular Biology

Structure, mechanism, and regulation of soluble adenylyl cyclases - similarities and differences to transmembrane adenylyl cyclases

Clemens Steegborn

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Review Endocrinology & Metabolism

Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)

Monalisa F. Azevedo et al.

ENDOCRINE REVIEWS (2014)

Article Medicine, Research & Experimental

Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways

Yasuhito Onodera et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Cell Biology

FSHR polymorphism p.N680S mediates different responses to FSH in vitro

Livio Casarini et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)

Article Oncology

Acidity Generated by the Tumor Microenvironment Drives Local Invasion

Veronica Estrella et al.

CANCER RESEARCH (2013)

Review Biochemistry & Molecular Biology

Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition

Feng Wang et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2013)

Review Cell Biology

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms

Russell Vang et al.

HISTOPATHOLOGY (2013)

Review Multidisciplinary Sciences

Cancer Genome Landscapes

Bert Vogelstein et al.

SCIENCE (2013)

Article Infectious Diseases

Viral and bacterial aetiologies of epithelial ovarian cancer

S. Shanmughapriya et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)

Review Cell Biology

Structure, function and regulation of gonadotropin receptors - A perspective

K. M. J. Menon et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)

Review Cardiac & Cardiovascular Systems

Bigger, Better, Faster: Principles and Models of AKAP Anchoring Protein Signaling

Eric C. Greenwald et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)

Review Medicine, Research & Experimental

The ovary: basic biology and clinical implications

JoAnne S. Richards et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Biochemistry & Molecular Biology

Spatial Regulation of Cyclic AMP-Epac1 Signaling in Cell Adhesion by ERM Proteins

Martijn Gloerich et al.

MOLECULAR AND CELLULAR BIOLOGY (2010)

Article Multidisciplinary Sciences

CREB Inhibits AP-2α Expression to Regulate the Malignant Phenotype of Melanoma

Vladislava O. Melnikova et al.

PLOS ONE (2010)

Article Cell Biology

Cyclic AMP Produced inside Mitochondria Regulates Oxidative Phosphorylation

Rebeca Acin-Perez et al.

CELL METABOLISM (2009)

Article Biochemistry & Molecular Biology

Spatial Distribution of Protein Kinase A Activity during Cell Migration Is Mediated by A-kinase Anchoring Protein AKAP Lbc

Adriana A. Paulucci-Holthauzen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Direct Spatial Control of Epac1 by Cyclic AMP

Bas Ponsioen et al.

MOLECULAR AND CELLULAR BIOLOGY (2009)

Article Cell Biology

Integrin-mediated Protein Kinase A Activation at the Leading Edge of Migrating Cells

Chinten J. Lim et al.

MOLECULAR BIOLOGY OF THE CELL (2008)

Article Multidisciplinary Sciences

Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B

Holger Rehmann et al.

NATURE (2008)

Article Endocrinology & Metabolism

cAMP response element-binding (CREB) signalling and ovarian surface epithelial cell survival

O. Gubbay et al.

JOURNAL OF ENDOCRINOLOGY (2006)

Article Biochemistry & Molecular Biology

Compartmentalization of adenylate cyclase and cAMP signalling

DMF Cooper

BIOCHEMICAL SOCIETY TRANSACTIONS (2005)

Article Multidisciplinary Sciences

Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration

AK Howe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Cell Biology

Bicarbonate-responsive soluble adenylyl cyclase defines a nuclear cAMP microdomain

JH Zippin et al.

JOURNAL OF CELL BIOLOGY (2004)

Review Cell Biology

AKAP signalling complexes: Focal points in space and time

W Wong et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)

Review Cell Biology

What turns CREB on?

M Johannessen et al.

CELLULAR SIGNALLING (2004)

Review Pharmacology & Pharmacy

Regulation and role of adenylyl cyclase isoforms

J Hanoune et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)